Research antibodies are widely used in biomedical sciences and proteomics research for various analytical and diagnostic applications such as investigating cell signaling pathways, validating disease biomarkers, and drug discovery. They help recognize and bind to specific proteins in biological samples which aids in visualization, purification, and quantification of target molecules. Growing investments by governments and private organizations in proteomics research present a lucrative opportunity in the research antibodies market. The global research antibodies market is estimated to be valued at US$ 3785.5 Bn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:
Proteomics research focuses on large-scale study of proteins expression, structure, localization, and interactions to better understand biological processes at the systems level. It enables researchers to identify novel disease biomarkers and drug targets which has widespread applications in pharmaceutical and biotechnological industries. Continuous advancements in proteomics technologies such as mass spectrometry and next generation sequencing has increased the scope and scale of proteomics studies. This growing demand for proteomics analysis presents a major market opportunity for research antibodies manufacturers to develop novel high specificity antibodies that can accelerate drug discovery and clinical proteomics research. Key players in the research antibodies market are focusing on expanding their antibody portfolio for proteomics applications by collaborating with research institutes and private labs.

Porter’s Analysis

Threat of new entrants: The threat of new entrants is moderate as the Research antibodies market requires high R&D investments and stringent regulatory approvals. However, new players can collaborate with established players and enter the market.

Bargaining power of buyers: The bargaining power of buyers is high due to the presence of many established players offering a variety of research antibodies. Buyers can negotiate on prices.

Bargaining power of suppliers: The bargaining power of suppliers is moderate as key raw materials like animals and reagents are available and there are alternative suppliers. Suppliers may face pressure on pricing from global buyers.

Threat of new substitutes: The threat of new substitutes is low as research antibodies have high specificity, sensitivity and are a critical reagents for research activities.

Competitive rivalry: High due to the presence of many global and local players offering a wide range of research antibodies with continuous innovations.

SWOT Analysis
Strength: Variety of research antibodies for different applications, established brands, global distribution network.
Weakness: High R&D costs, stringent regulations,pricing pressure from buyers.
Opportunity: Increasing research activities, growth in genomics and proteomics, collaborations for new antibody development.
Threats: Biosimilars, trade barriers, intellectual property thefts.

Key Takeaways

The global Research Antibodies Market Share is expected to witness high growth. The market size is projected to grow from US$ 3785.5 Bn in 2023 to US$ 6146.5 Bn by 2030 at a CAGR of 5.9% during the forecast period. North America is currently the dominant region holding around 35% of the global market share due to increasing R&D investments by pharma-biotech companies and presence of key players. The U.S. holds the major share in the North America research antibodies market. However, the Asia Pacific region is expected to grow at the fastest pace owing to emerging economies like China and India strengthening their research infrastructure along with widening application areas.
Regional analysis

The Asia Pacific region is projected to grow at the highest CAGR during the forecast period. This is attributed to rising biomedical research activities in emerging countries like India and China along with favorable government policies supporting life science research. India and China are witnessing significant boost in their research infrastructure development projects including expansion of academia-industry collaborations. In addition, growing presence of key research antibodies market players through partnerships and acquisitions is also pushing the market growth. For instance, in 2021, Thermo Fisher Scientific acquired genetic analysis instruments maker PPD to strengthen its bioanalytical testing capabilities and expand presence in Asia Pacific region.

Key players operating in the research antibodies market are Thermo Fisher Scientific Inc, Bio-rad Laboratories, Lonza Group, Merck Millipore, Cell Signalling Technology Inc., F.Hoffmann La Roche Ltd., Novartis AG, Takeda Pharmaceutical Company, Agilent Technologies, Danaher Corporation, BioLegend Inc., Illumina.
 

For more insights, read- https://www.pressreleasebulletin.com/research-antibodies-market-trends-size-and-share-analysis/